![Genmab A/S Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gmab.png?tr=w-200)
Genmab A/S
NASDAQ:GMAB
![Genmab A/S Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gmab.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24.85
38.53
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/gmab.png)
Genmab A/S
Net Income (Common)
Genmab A/S
Net Income (Common) Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/glto.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nasdaq/asnd.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/cse/biopor.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/sto/sanion.png)
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Genmab A/S
NASDAQ:GMAB
|
Net Income (Common)
kr5.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
36%
|
CAGR 10-Years
45%
|
![]() |
Galecto Inc
NASDAQ:GLTO
|
Net Income (Common)
-$38.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
![]() |
Ascendis Pharma A/S
NASDAQ:ASND
|
Net Income (Common)
-€501.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Net Income (Common)
kr707.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Bioporto A/S
CSE:BIOPOR
|
Net Income (Common)
-kr50m
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-10%
|
![]() |
Saniona AB
STO:SANION
|
Net Income (Common)
-kr83.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
See Also
What is Genmab A/S's Net Income (Common)?
Net Income (Common)
5.5B
DKK
Based on the financial report for Jun 30, 2024, Genmab A/S's Net Income (Common) amounts to 5.5B DKK.
What is Genmab A/S's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
45%
Over the last year, the Net Income (Common) growth was 16%. The average annual Net Income (Common) growth rates for Genmab A/S have been 30% over the past three years , 36% over the past five years , and 45% over the past ten years .